CymaBay Therapeutics, Inc.·4

Jan 20, 4:35 PM ET

KIM DENNIS D 4

4 · CymaBay Therapeutics, Inc. · Filed Jan 20, 2022

Insider Transaction Report

Form 4
Period: 2022-01-19
KIM DENNIS D
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2022-01-19$3.04/sh+20,000$60,80020,000 total

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES